National Summary Report
Latest data from August 2023
HRSA uses the information collected to: optimize COVID-19 testing and vaccination; track health center capacity and the impact of COVID-19 on operations, patients, and staff; and better understand training and technical assistance, funding, and other health center resource needs.
Health Center COVID-19 Survey Tool Questions
Health Center COVID-19 Survey Tool User Guide
Health Center Program Look-Alike Survey Data for COVID-19
Number of Health Center respondents = 920 (67% of all Health Centers)
Data represents information provided by health centers funded through H80 grants from a single, specified monthly reporting date as indicated above. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Survey Results
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 179,701 |
| COVID-19 Vaccination Doses Administered |
11,625 |
| Percent of COVID-19 Vaccination Doses Administered to Racial and Ethnic Minorities | 78.36% |
| Percent of Health Centers Hosting Community-Based Events (Mobile Vans, Pop-Up Clinics, School-Based Sites, or Family Vaccination Clinics) | 22.17% |
| Number of Community-Based Events | 1,524 |
| Number of Collaboration Community-Based Events | 599 |
| Percent of Health Centers Administer Vaccines from Vaccine Program | 19.35% |
| Percent of Health Centers Distribute Test Kits from HRSA | 41.30% |
| Percent of Health Centers Distribute Oral Antiviral Medication from HRSA | 23.59% |
| COVID-19 Vaccination Doses Administered Through Health Center COVID-19 Vaccine Program | 11,625 |
| Percent of Health Center COVID-19 Vaccine Program Doses Administered to Racial and Ethnic Minorities | 78.36% |
| Percent of Health Center COVID-19 Vaccine Program Doses Administered to Special Populations | 78.95% |
| Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 146,315 |
| Number of Patients Who Received COVID-19 Oral Antiviral Medication | 4,349 |
| Percent of COVID-19 Oral Antiviral Medications Given to Racial and Ethnic Minorities | 77.78% |
| Percent of COVID-19 Oral Antiviral Medications Given to Special Populations | 50.72% |
Date Last Reviewed: